Navigation Links
New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
Date:9/16/2007

Computer Assisted Surgery at the Forefront

SACRAMENTO, Calif., Sept. 16 /PRNewswire/ -- Novatrix Biomedical, Inc. announced today that it has formed a new company, Curexo Medical, Inc. (CMI), with the acquisition of all assets of Integrated Surgical Services, Inc. (ISS). Under the licensing agreement, Curexo, Inc., will transfer all the assets acquired from ISS to CMI.

Curexo Medical, Inc., located in Sacramento, California, retained the former officers and employees of ISS in order to facilitate rapid introduction of its surgical robotics system into the U.S. orthopedic market. The system is called ROBODOC(R) Surgical Assistant System (the ROBODOC). The ROBODOC has been very well received by hospitals and orthopedic surgeons from both academic institutions and private hospitals in Europe and Asia, including Japan, Korea and India. The system has already been approved by Korea's regulatory agency, KFDA.

"CMI's mission is to make computer assisted surgery a gold standard for all major orthopedic surgeries by the year 2012 and to be the world leader in this market segment," said Dr. Ramesh Trivedi, President and CEO.

"We have already received funding from Novatrix and have been assured of future funding to accomplish our goals," said Trivedi. "We are actively recruiting highly qualified and experienced staff to rapidly grow the business."

Novatrix Biomedical, Inc., based in Southern California, develops proprietary technologies in the drug delivery field. "We firmly believe that CMI has the right strategy, a well thought out plan and a highly experienced team in place to be a dominant player in the orthopedic surgical robotics field," said Dr. Soon Kap Hahn, President and CEO of Novatrix Biomedical.

"Along with our partner, Curexo Inc., Korea, we are committed to fund CMI to secure U.S. Food and Drug Administration (FDA) clearance, enter the U.S. market and continue building the ongoing business in other major markets of the world."

Curexo Medical, Inc. also announced that it has submitted a 510(k) pre-market notification to the U.S. FDA for the clearance of its ROBODOC Surgical Assistance System for marketing in the U.S. A 90-day period is customary for FDA review of a 510(k) submission.

http://www.robodoc.com

Contact: Media Contact

Dr. Ramesh C. Trivedi Tami Adachi

President & CEO 415-370-9638

Curexo Medical, Inc. tadachi@mindspring.com

916-285-9943, X511


'/>"/>
SOURCE Curexo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Phillips Plastics to help develop orthopedics with stem cells
2. Evaluation of RNA isolated from human tissues: quality control for surgical and postmortem samples
3. Surgical products company wins Governors Business Plan Contest
4. Vector Surgical hopes to turn frustration into faster surgeries
5. KUKA Robotics set to unveil Appleton training center
6. Fox Valley Tech, Kuka Robotics team up on high-tech training center
7. Germantown drug company hires pharma veteran James Davidson as COO
8. Georgia stem cell company likely to stay put
9. Madison stem cell company gets $1M from state
10. Company still behind schedule on Milwaukee wireless project
11. Software company enters health space with RFID solutions on hold
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), ... the ability of the Aethlon Hemopurifier® to capture latent ... immune-suppressed sepsis patients and also contribute to organ rejection ... the study was to validate the in vitro ... Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. The ...
(Date:2/22/2017)... SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, ... UTHR ) today announced its financial results for ... "Our annual 2016 financial results reflect ... and earnings exceeded $700 million," said Martine Rothblatt, ... "These financial results strengthen our ability to develop ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... ... the VTX-1 Liquid Biopsy System , a fully automated benchtop system for ... technology. The VTX-1 is being launched at the Molecular Medicine Tri Conference (Tri-Con) ...
(Date:2/21/2017)... , ... February 21, 2017 ... ... Life -Sciences division, Treximo will pair its $200M operational capacity with its ... and project management in areas affecting quality and operational management. With ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
Breaking Biology News(10 mins):